je.st
news
Vertex sinks after FDA freezes portion of hepatitis drug trial
2013-07-26 19:57:48| Biotech - Topix.net
Investors pounded Vertex Pharmaceuticals in after-hours trading Thursday after the company announced that the U.S. Food and Drug Administration had placed a partial hold on a drug trial for a hepatitis C therapy that may have contributed to liver toxicity in some patients.
Tags: trial
drug
portion
fda
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||